Atlas Trials

Protective Role of Oxcarbazepine in Multiple Sclerosis

Clinical trial NCT02104661 · COMPLETED

Trial details

NCT number
NCT02104661
Sponsor
Queen Mary University of London
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Multiple Sclerosis
Start date
2014-10-01
Primary completion
2018-01-31
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.